Ziva Pogacar

418 total citations
8 papers, 267 citations indexed

About

Ziva Pogacar is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Ziva Pogacar has authored 8 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Physiology. Recurrent topics in Ziva Pogacar's work include CRISPR and Genetic Engineering (3 papers), Telomeres, Telomerase, and Senescence (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Ziva Pogacar is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), Telomeres, Telomerase, and Senescence (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Ziva Pogacar collaborates with scholars based in Netherlands, Slovenia and Germany. Ziva Pogacar's co-authors include George A. Călin, Simon Horvat, Jana Obšteter, Tanja Kunej, René Bernards, Fleur Jochems, Liqin Wang, Arnout Schepers, Roderick L. Beijersbergen and Giulia De Conti and has published in prestigious journals such as PLoS ONE, Cell Reports and The Journal of Membrane Biology.

In The Last Decade

Ziva Pogacar

8 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziva Pogacar Netherlands 7 179 105 93 44 34 8 267
Shiran Rabinovich Israel 3 211 1.2× 171 1.6× 17 0.2× 19 0.4× 24 0.7× 3 303
Alona Sarver Israel 2 221 1.2× 167 1.6× 19 0.2× 16 0.4× 20 0.6× 2 307
Miriam Kull Germany 8 279 1.6× 17 0.2× 86 0.9× 19 0.4× 61 1.8× 16 335
Paolo Falvo Italy 8 81 0.5× 31 0.3× 26 0.3× 86 2.0× 94 2.8× 19 198
Ergang Wang United States 7 65 0.4× 33 0.3× 15 0.2× 32 0.7× 41 1.2× 9 181
Miljana Nenkov Germany 10 171 1.0× 125 1.2× 14 0.2× 29 0.7× 64 1.9× 12 267
Ceyda Durmaz United States 3 109 0.6× 25 0.2× 37 0.4× 39 0.9× 44 1.3× 5 170
Ranit D’Rozario India 5 77 0.4× 66 0.6× 15 0.2× 83 1.9× 39 1.1× 9 172
Im-Meng Sun United States 4 160 0.9× 157 1.5× 14 0.2× 220 5.0× 97 2.9× 7 366
Ying Kong China 6 179 1.0× 133 1.3× 22 0.2× 30 0.7× 23 0.7× 9 288

Countries citing papers authored by Ziva Pogacar

Since Specialization
Citations

This map shows the geographic impact of Ziva Pogacar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziva Pogacar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziva Pogacar more than expected).

Fields of papers citing papers by Ziva Pogacar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziva Pogacar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziva Pogacar. The network helps show where Ziva Pogacar may publish in the future.

Co-authorship network of co-authors of Ziva Pogacar

This figure shows the co-authorship network connecting the top 25 collaborators of Ziva Pogacar. A scholar is included among the top collaborators of Ziva Pogacar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziva Pogacar. Ziva Pogacar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pogacar, Ziva, Jackie Johnson, Lenno Krenning, et al.. (2022). Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity. PLoS ONE. 17(9). e0273182–e0273182. 12 indexed citations
2.
Pogacar, Ziva, Fleur Jochems, Antonio Mulero‐Sánchez, et al.. (2022). Genetic and compound screens uncover factors modulating cancer cell response to indisulam. Life Science Alliance. 5(9). e202101348–e202101348. 8 indexed citations
3.
Schepers, Arnout, Fleur Jochems, Cor Lieftink, et al.. (2021). Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen. Molecular Cancer Research. 19(10). 1613–1621. 5 indexed citations
4.
Jochems, Fleur, Bram Thijssen, Giulia De Conti, et al.. (2021). The Cancer SENESCopedia: A delineation of cancer cell senescence. Cell Reports. 36(4). 109441–109441. 122 indexed citations
5.
Jochems, Fleur, Bram Thijssen, Giulia De Conti, et al.. (2021). The Cancer Senescopedia – Delineation of Cancer Cell Senescence. SSRN Electronic Journal. 10 indexed citations
6.
Mulero‐Sánchez, Antonio, Ziva Pogacar, & Loredana Vecchione. (2019). Importance of genetic screens in precision oncology. ESMO Open. 4(3). e000505–e000505. 7 indexed citations
7.
Bošnjak, Maša, et al.. (2014). Different Incubation Times of Cells After Gene Electrotransfer in Fetal Bovine Serum Affect Cell Viability, but Not Transfection Efficiency. The Journal of Membrane Biology. 247(5). 421–428. 14 indexed citations
8.
Kunej, Tanja, Jana Obšteter, Ziva Pogacar, Simon Horvat, & George A. Călin. (2014). The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. Critical Reviews in Clinical Laboratory Sciences. 51(6). 344–357. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026